Lv11
60 积分 2024-09-21 加入
Developments in pneumonia and priorities for research
14小时前
待确认
SGLT-2 inhibitors in Diabetic Kidney Disease: What Lies Behind their Renoprotective Properties?
29天前
已完结
Hypoxia‐induced HE4 in tubular epithelial cells promotes extracellular matrix accumulation and renal fibrosis via NF‐κB
1个月前
已完结
Dapagliflozin attenuates high glucose‐induced endothelial cell apoptosis and inflammation through AMPK/SIRT1 activation
1个月前
已完结
Protective effects of Empagliflozin against Transforming growth factor‐beta‐induced fibrosis in renal proximal tubular cells
2个月前
已关闭
Systemic and organ-specific anti-inflammatory effects of sodium-glucose cotransporter-2 inhibitors
2个月前
已完结
Lipid effects of sodium-glucose cotransporter 2 inhibitors
2个月前
已完结
Antifibrotic effects of sodium-glucose cotransporter-2 inhibitors: A comprehensive review
2个月前
已完结
[The mechanisms and clinical potential: sodium-glucose cotransporter 2 (SGLT-2) inhibitors treating diabetic kidney disease]
2个月前
已关闭
Conditioned Place Preference Test for Assessing the Rewarding Effects of Drugs of Abuse
3个月前
已完结
皖公网安备34019202002308
